Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
- PMID: 16141388
- DOI: 10.1210/en.2005-0938
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
Abstract
Hyperglycemia is associated with altered myocardial substrate use, a condition that has been hypothesized to contribute to impaired cardiac performance. The goals of this study were to determine whether changes in cardiac metabolism, gene expression, and function precede or follow the onset of hyperglycemia in two mouse models of obesity, insulin resistance, and diabetes (ob/ob and db/db mice). Ob/ob and db/db mice were studied at 4, 8, and 15 wk of age. Four-week-old mice of both strains were normoglycemic but hyperinsulinemic. Hyperglycemia develops in db/db mice between 4 and 8 wk of age and in ob/ob mice between 8 and 15 wk. In isolated working hearts, rates of glucose oxidation were reduced by 28-37% at 4 wk and declined no further at 15 wk in both strains. Fatty acid oxidation rates and myocardial oxygen consumption were increased in 4-wk-old mice of both strains. Fatty acid oxidation rates progressively increased in db/db mice in parallel with the earlier onset and greater duration of hyperglycemia. In vivo, cardiac catheterization revealed significantly increased left ventricular contractility and relaxation (positive and negative dP/dt) in both strains at 4 wk of age. dP/dt declined over time in db/db mice but remained elevated in ob/ob mice at 15 wk of age. Increased beta-myosin heavy chain isoform expression was present in 4-wk-old mice and persisted in 15-wk-old mice. Increased expression of peroxisomal proliferator-activated receptor-alpha regulated genes was observed only at 15 wk in both strains. These data indicate that altered myocardial substrate use and reduced myocardial efficiency are early abnormalities in the hearts of obese mice and precede the onset of hyperglycemia. Obesity per se does not cause contractile dysfunction in vivo, but loss of the hypercontractile phenotype of obesity and up-regulation of peroxisomal proliferator-activated receptor-alpha regulated genes occur later and are most pronounced in the presence of longstanding hyperglycemia.
Similar articles
-
Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders.Ann Nutr Metab. 2016;68 Suppl 3:15-20. doi: 10.1159/000448357. Epub 2016 Dec 9. Ann Nutr Metab. 2016. PMID: 27931032 Review.
-
Fatty acid metabolism is enhanced in type 2 diabetic hearts.Biochim Biophys Acta. 2005 May 15;1734(2):112-26. doi: 10.1016/j.bbalip.2005.03.005. Epub 2005 Apr 9. Biochim Biophys Acta. 2005. PMID: 15904868 Review.
-
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.Diabetes. 2004 Sep;53(9):2366-74. doi: 10.2337/diabetes.53.9.2366. Diabetes. 2004. PMID: 15331547
-
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.Endocrinology. 2000 Nov;141(11):4021-31. doi: 10.1210/endo.141.11.7771. Endocrinology. 2000. PMID: 11089532
-
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1104-13. doi: 10.1152/ajpendo.2000.279.5.E1104. Am J Physiol Endocrinol Metab. 2000. PMID: 11052966
Cited by
-
Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction.J Clin Med. 2024 Feb 20;13(5):1195. doi: 10.3390/jcm13051195. J Clin Med. 2024. PMID: 38592048 Free PMC article. Review.
-
Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.Diabetes. 2024 May 1;73(5):659-670. doi: 10.2337/dbi23-0019. Diabetes. 2024. PMID: 38387045 Free PMC article. Review.
-
Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice.Basic Res Cardiol. 2024 Feb;119(1):133-150. doi: 10.1007/s00395-023-01020-2. Epub 2023 Dec 26. Basic Res Cardiol. 2024. PMID: 38148348
-
Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells.Front Pharmacol. 2023 Dec 5;14:1228646. doi: 10.3389/fphar.2023.1228646. eCollection 2023. Front Pharmacol. 2023. PMID: 38116084 Free PMC article.
-
Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models.Channels (Austin). 2023 Dec;17(1):2281743. doi: 10.1080/19336950.2023.2281743. Epub 2023 Nov 20. Channels (Austin). 2023. PMID: 37983306 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous